Christian Weyer

Sr. VP Research & Development, Amylin Pharmaceuticals.

Companies

Intercept PharmaceuticalsEVP Research and Development Dec 11, 2017 to Apr 5, 2021¹
Fate TherapeuticsBoard member Sep 30, 2013 to Apr 14, 2015²
Fate TherapeuticsOfficer Sep 30, 2013 to Apr 14, 2015²
Amylin PharmaceuticalsSr. VP Research & Development Jun 9, 2010 to Feb 24, 2012³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIntercept Pharmaceuticals, EVP Research and Development
2
SEC EDGARFate Therapeutics, Board member
3
SEC EDGARAmylin Pharmaceuticals, Sr. VP Research & Development